These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31915968)

  • 1. The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors.
    Parker WB; Allan PW; Waud WR; Hong J; Gilbert-Ross M; Achyut BR; Joshi D; Behbahani T; Rab R; Ealick SE; Sorscher EJ
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):573-583. PubMed ID: 31915968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.
    Hong JS; Waud WR; Levasseur DN; Townes TM; Wen H; McPherson SA; Moore BA; Bebok Z; Allan PW; Secrist JA; Parker WB; Sorscher EJ
    Cancer Res; 2004 Sep; 64(18):6610-5. PubMed ID: 15374975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.
    Sorscher EJ; Hong JS; Allan PW; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):321-9. PubMed ID: 22760227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Hassan AE; Secrist JA; Sorscher EJ; Waud WR
    Cancer Gene Ther; 2003 Jan; 10(1):23-9. PubMed ID: 12489025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.
    Parker WB; King SA; Allan PW; Bennett LL; Secrist JA; Montgomery JA; Gilbert KS; Waud WR; Wells AH; Gillespie GY; Sorscher EJ
    Hum Gene Ther; 1997 Sep; 8(14):1637-44. PubMed ID: 9322865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex.
    Zang Y; Wang WH; Wu SW; Ealick SE; Wang CC
    J Biol Chem; 2005 Jun; 280(23):22318-25. PubMed ID: 15817485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues.
    Rinaldo-Matthis A; Wing C; Ghanem M; Deng H; Wu P; Gupta A; Tyler PC; Evans GB; Furneaux RH; Almo SC; Wang CC; Schramm VL
    Biochemistry; 2007 Jan; 46(3):659-68. PubMed ID: 17223688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The purine nucleoside phosphorylase from Trichomonas vaginalis is a homologue of the bacterial enzyme.
    Munagala N; Wang CC
    Biochemistry; 2002 Aug; 41(33):10382-9. PubMed ID: 12173924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
    Tai CK; Wang W; Lai YH; Logg CR; Parker WB; Li YF; Hong JS; Sorscher EJ; Chen TC; Kasahara N
    Cancer Gene Ther; 2010 Sep; 17(9):614-23. PubMed ID: 20467451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Waud WR; Hong JS; Sorscher EJ
    Cancer Gene Ther; 2011 Jun; 18(6):390-8. PubMed ID: 21394111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy.
    Bharara S; Sorscher EJ; Gillespie GY; Lindsey JR; Hong JS; Curlee KV; Allan PW; Gadi VK; Alexander SA; Secrist JA; Parker WB; Waud WR
    Hum Gene Ther; 2005 Mar; 16(3):339-47. PubMed ID: 15812229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA; Abou-Elkhair RAI; Parker WB; Allan PW; Secrist JA
    Eur J Med Chem; 2016 Jan; 108():616-622. PubMed ID: 26724729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors.
    Rosenthal EL; Chung TK; Parker WB; Allan PW; Clemons L; Lowman D; Hong J; Hunt FR; Richman J; Conry RM; Mannion K; Carroll WR; Nabell L; Sorscher EJ
    Ann Oncol; 2015 Jul; 26(7):1481-7. PubMed ID: 25899782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient-derived xenografts.
    Rab R; Ehrhardt A; Achyut BR; Joshi D; Gilbert-Ross M; Huang C; Floyd K; Borovjagin AV; Parker WB; Sorscher EJ; Hong JS
    Cancer Rep (Hoboken); 2023 Feb; 6(2):e1708. PubMed ID: 36253876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Fludarabine-Activating PNP From Archaea as a Guidance for Redesign the Active Site of E. Coli PNP.
    Cacciapuoti G; Bagarolo ML; Martino E; Scafuri B; Marabotti A; Porcelli M
    J Cell Biochem; 2016 May; 117(5):1126-35. PubMed ID: 26477689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.
    Mohr L; Shankara S; Yoon SK; Krohne TU; Geissler M; Roberts B; Blum HE; Wands JR
    Hepatology; 2000 Mar; 31(3):606-14. PubMed ID: 10706550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE; Duncan GF; El Dareer SM; Hill DL
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.
    Voeks D; Martiniello-Wilks R; Madden V; Smith K; Bennetts E; Both GW; Russell PJ
    Gene Ther; 2002 Jun; 9(12):759-68. PubMed ID: 12040457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
    Wang XY; Martiniello-Wilks R; Shaw JM; Ho T; Coulston N; Cooke-Yarborough C; Molloy PL; Cameron F; Moghaddam M; Lockett TJ; Webster LK; Smith IK; Both GW; Russell PJ
    Gene Ther; 2004 Nov; 11(21):1559-67. PubMed ID: 15343359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.